相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome
Lucrezia Laterza et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Jasmohan S. Bajaj et al.
HEPATOLOGY (2015)
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed
Sudhir Maharshi et al.
GUT (2015)
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics
Sari Tuomisto et al.
BMC GASTROENTEROLOGY (2014)
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
Kevin D. Mullen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Is Rifaximin Effective in Maintaining Remission in Crohn's Disease?
Anca Olivia Jigaranu et al.
DIGESTIVE DISEASES (2014)
Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats
Dabo Xu et al.
GASTROENTEROLOGY (2014)
Meta'omic Analytic Techniques for Studying the Intestinal Microbiome
Xochitl C. Morgan et al.
GASTROENTEROLOGY (2014)
Rifaximin: beyond the traditional antibiotic activity
Fiorella Calanni et al.
JOURNAL OF ANTIBIOTICS (2014)
Pathological bacterial translocation in liver cirrhosis
Reiner Wiest et al.
JOURNAL OF HEPATOLOGY (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites
Philipp Lutz et al.
PLOS ONE (2014)
Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers
Corrado Blandizzi et al.
PHARMACOLOGICAL RESEARCH (2014)
Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis
Valerio Giannelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial
Kapil Sharma et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2014)
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
Rossella Cianci et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Rifaximin, gut microbes and mucosal inflammation: unraveling a complex relationship
Jun Gao et al.
GUT MICROBES (2014)
Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: An evidence-based review
M. Schmulson et al.
REVISTA DE GASTROENTEROLOGIA DE MEXICO (2014)
A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
Barjesh Chander Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing
Zhigang Zhang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
Xiao Wei et al.
BMC GASTROENTEROLOGY (2013)
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
Jiannis Vlachogiannakos et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
PLOS ONE (2013)
Ascitic Microbiota Composition Is Correlated with Clinical Severity in Cirrhosis with Portal Hypertension
Geraint B. Rogers et al.
PLOS ONE (2013)
New strategies for the management of diverticular disease: insights for the clinician
Wen Boynton et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Linkage of gut microbiome with cognition in hepatic encephalopathy
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain
Martina Bielaszewska et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center
Puneeta Tandon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Rifaximin for the treatment of irritable bowel syndrome
Filippo Cremonini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
Cosimo Prantera et al.
GASTROENTEROLOGY (2012)
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
Georgios N. Kalambokis et al.
HEPATOLOGY (2012)
Durability of Rifaximin Response in Hepatic Encephalopathy
Guy W. Neff et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
Mohamad A. Hanouneh et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia
Georgios N. Kalambokis et al.
LIVER INTERNATIONAL (2012)
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
A. Sanyal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
Sandeep Singh Sidhu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Rifaximin Therapy in Minimal Hepatic Encephalopathy Cirrhotics
Angelo Zullo et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Inflammation and gastrointestinal Candida colonization
Carol A. Kumamoto
CURRENT OPINION IN MICROBIOLOGY (2011)
Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells
Andrea Mencarelli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
GASTROENTEROLOGY (2011)
Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis
Yanfei Chen et al.
HEPATOLOGY (2011)
Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts?
Georgios Kalambokis et al.
MEDICAL HYPOTHESES (2011)
Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection
Haifeng Lu et al.
MICROBIAL ECOLOGY (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rifaximin in the treatment of inflammatory bowel disease
Mario Guslandi
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles
Eric L. Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Characterisation of bacteria in ascites-reporting the potential of culture-independent, molecular analysis
G. B. Rogers et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Drug Therapy: Rifaximin
Jasmohan S. Bajar et al.
HEPATOLOGY (2010)
Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system
Simone Maccaferri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas
Z-D Jiang et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
J. Vlachogiannakos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis
Beatrice Vitali et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Rifaximin for the Treatment of Newly Diagnosed Crohn's Disease: A Case Series
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease
Antonio Colecchia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
C Prantera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Rifaximin for active ulcerative colitis
M Guslandi et al.
INFLAMMATORY BOWEL DISEASES (2006)
An open-label evaluation of rifaximin in the treatment of active Crohn's disease
I Shafran et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Rifaximin, a poorly absorbed antibiotic: Pharmacology and clinical potential
C Scarpignato et al.
CHEMOTHERAPY (2005)
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon
G Latella et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2003)
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis
P Brigidi et al.
JOURNAL OF CHEMOTHERAPY (2002)
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial
HL DuPont et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
